How Trends in GLP-1-Support, Gut-Brain Axis, and Advanced Delivery Techs are Driving Industry Innovation

Sebastian Krawiec, Managing Editor of Nutritional Outlook, recently sat down with Lauren Clardy to welcome her as the newest member of the publication's editorial advisory board. Clardy brings a wealth of expertise to the table, currently serving as the Senior Director for Branded Ingredients at Maypro and the principal of NutriMarket Business.

With a career spanning over 25 years across the nutraceutical, health, and wellness industries, Clardy possesses a unique, end-to-end perspective of the value chain. Her early career involved scaling up legacy consumer packaged goods (CPG) brands like Nordic Naturals and Traditional Medicinals, giving her foundational insights into what brands need to thrive in a competitive marketplace. Over the last 15 years, her focus has shifted to the ingredient side, where she specializes in botanicals, novel ingredients, and advanced delivery technologies. Today, her expertise lies in bridging the gap between rigorous clinical science and commercial viability, ensuring that science-backed ingredients are translated into trusted, scalable solutions for consumers.

Clardy shares her vantage point on the industry's most compelling shifts. She breaks down the transition of mood and sleep support from niche categories to foundational health pillars and explores the explosive mainstream dialogue surrounding GLP-1 therapies and the biology of weight management. Clardy also discusses the exciting convergence of Eastern traditional medicine with clinical validation, the evolution of targeted cognitive wellness solutions, and the transformational potential of artificial intelligence across the industry.

Sebastian Krawiec: Can you tell us about your background and how you got into the industry?

Lauren Clardy: My experience really spans the full value chain from the CPG side early in my career to the ingredient side where I focused for the last fifteen years. I started out in the industry right out of college, working for market leading brands like Nordic Naturals and Traditional Medicinals, where I was involved in helping scale up those companies from early stage growth into well established category leaders. And that foundation really gave me a strong understanding of what brands need to succeed in the marketplace. And over the course of my career on the CPG side, I've been directly involved in the development and scale up of hundreds of dietary supplement formulations for both emerging and legacy brands. And that deep perspective has given me how to bring products to market and also how to scale them successfully. While I have a deep understanding on the brand side, my core expertise is really on the ingredient side, particularly around commercialization, scale up and aligning strategy with market needs. My sweet spot is really working with botanicals, novel ingredients and advanced delivery technologies. I've worked with market leading botanical suppliers, innovative ingredient developers, and most recently in my career, distributors supporting the growth and positioning of branded ingredients. In my current role at Maypro, I focus on translating clinically supported ingredients into unique, market ready opportunities. More broadly, I focus on ingredient positioning and innovation strategy, ensuring that science based, science backed products, are not only credible, credible, but commercially viable. What's been consistent throughout my career is really bridging the gap between science and commercial success, taking complex data and translating it into something meaningful and relevant and scalable in the marketplace, and ultimately something that consumers can understand and trust.

SK: In your time in industry. I'm sure you've seen a lot of trends come and go. You can call them fads sometimes, but some of some trends obviously hold true for a while. And, you know, as you see them evolve and change, I wonder kind of from your view what are some of the biggest trends happening right now that interest you?

LC: We're seeing sustained strong growth across mood, stress and sleep, clearly established now as foundational pillars of health rather than niche categories, which they were in the past. This is closely tied to the increasing focus on the mental load. I call it the mental load. And it's a concept that reflects the cumulative cognitive and emotional burden that all of us are managing daily, which in turn is expanding into broader cognitive health needs and solutions. And at the same time, women's health continues to move to the forefront as a priority area for innovation and investment and formulation. So I look at those as, you know, four trends or four categories that are going to continue to accelerate. Another major driver to me is the rapid expansion of science around the gut-brain-axis and the microbiome. Ingredients are, you know, more and more are being positioned beyond traditional digestive support. They've moved out of this area to address mental wellbeing and systemic health outcomes. This is fueling significant growth in new foundational strains, which we've seen hit the market and Akkermansia being one of them, including including novel probiotic strains as well as interesting postbiotics and prebiotics are also coming to the forefront. So as the industry looks to more targeted and mechanistic supported solutions, these to me are some of the key areas.

Another important shift, and this one is really near and dear to my heart, a topic that I am very interested in talking about and discussing further is the emergence of the whole GLP-1 movement and the GLP-1 consumer. Of course, driven by the rapid adoption of Semaglutides. Today I think the estimation is twenty million consumers that are using GLP-1 therapies and it's projected to grow to over fifty million over the next five years. But what is most important that I really want to talk about is what has really changed is the narrative. We're seeing a fundamental shift in how we understand weight management. It's it's no longer about just diet and exercise, which it was when I started in this industry, but it's about biology, metabolism, and brain chemistry. The conversation has moved into the mainstream, in part through voices like many of the movie stars that have been on GLP-1 agonists that have been on social media, etc., as well as voices like Oprah Winfrey and her book called "Enough" which is co-written by an MD, by the way, I don't recall her name. And it really highlights the concept of food noise.

That constant internal dialogue around hunger, cravings and control. GPL-1s are really redefining what weight management is. It's no longer about willpower. It's about biology. And as Oprah has highlighted in her book, the concept of food noise is this constant internal struggle isn't a failure of us. It's about how our brain is wired. And that shift is really opening the door for a whole new category of targeted nutritional solutions and a significant opportunity for the nutraceutical industry to play a complementary role supporting all of the side effects of GLP-1 use. Whether it's supporting muscle preservation or metabolic health or nutrient density, hydration and overall wellness for the rapidly growing segment of consumers. So to me, that's a really key trend that we're going to see accelerate and get larger.

Another big shift is the continued move towards clinically validated ingredients that are paired with more advanced delivery technologies. I've been looking into delivery technologies since 2014, and many of these are really being adapted from pharma. And as the cost comes down, they're significantly improving bioavailability, stability and overall efficacy of nutraceuticals. So they're coming over to our side of the industry, away from pharma and into nutra. A perfect example is the new forms of magnesium, and better bioavailability due to solubility technologies like liposomes and other, matrices. So it's no longer just about what the ingredient is. It's also about how it effectively performs in the body and how is it how it is absorbed. And this also ties into personalization and tracking technology like wearables too. That is definitely accelerating, in the market. But ultimately the real opportunity lies in bringing this all together. Strong science, advanced delivery technologies, and clearly defined benefits to really create products that deliver measurable results for today's consumer.

SK: Of all of these trends, what kind of really personally excites you about, you know, the direction the industry is taking?

LC: Honestly, it's really hard to pick one thing because the industry is evolving so quickly. But you know, my background, my academic background is in nutrition and I've seen the field undergo tremendous change. What we believed and what I was taught, 10, 20, 30 years ago has in many cases been refined or completely redefined as the science has advanced. So to me, that's what makes this industry so exciting is that nutrition is not static. It's constantly evolving as new data emerges. One of the most encouraging shifts to me, um, is the growing integration of eastern and traditional medicine into modern nutrition science. We're starting to really see more holistic system based approaches take shape, where botanical medicine and traditional practices are being validated through clinical research. There's still a lot of progress to be made, but it's a meaningful step forward. And the medical industry is also starting to embrace this.

From a trend perspective, I'm particularly excited about, as I mentioned earlier, areas like gut-brain-axis, and the microbiome and how they deeply influence not only just digestion, but mood, cognition, overall health, lifespan, and even beauty-from-within. Another trending application area like cognitive wellness and brain health, I think are experiencing a real surge of innovation from new clinically researched ingredients hitting the market to new areas rising in popularity. I think brain health is really getting segmented into areas like working memory, short term memory, age related cognitive decline and executive function. Even gaming that includes speed and hand-eye coordination is coming to the forefront. I predict we will continue to see these areas innovate and trend up upward. And then as I mentioned earlier, we're also seeing a fundamental shift in how we understand weight management moving towards biology, metabolic science, and brain chemistry, not just the old models of just exercise and eat well and you'll be fine.

Then of course, the, the big elephant in the room is AI. I really believe that this is going to be transformational across our entire value chain, from ingredient discovery to clinical research to formulation, personalization, and commercialization, as well as the consumer is going to be, of course, tapping into AI. So it's going to enable a level of precision and speed that we've never seen before. So for me, it's the convergence of all these forces, all these forces, um, advancing science, more holistic thinking, and new technologies that make this such an exciting time to be in the nutrition industry.